Articles & News for Medical Professionals

Ian Neeland, MD

Showing of 5 results

Fat cells, adipocyte and lipocyte, cholesterol in a cells

From GLP-1 to Triple Agonists: Transforming Cardiometabolic Care

Ian Neeland, MD, explains how incretin therapies are improving outcomes in cardiovascular, metabolic, and related conditions, while exploring mechanisms, muscle preservation, and strategies for long-term success.

5/21/2026 By Daniel Simon, MD and Ian Neeland, MD

Read Article

Ian Neeland, MD UH Cardiovascular Medicine discussing in conference room

Leaders of Successful Cardiometabolic Program at University Hospitals Detail Essential Components

Innovations in Cardiovascular Medicine & Surgery | February 2025

2/6/2025 By Ian Neeland, MD and Sanjay Rajagopalan, MD

Read Article

University Hospitals Preventive Cardiologist Authors Primer on Muscle Effects of GLP-1s

Innovations in Cardiovascular Medicine & Surgery | December 2024

12/9/2024 By Ian Neeland, MD and UH

Read Article

UH Harrington Heart & Vascular Institute Preventive Cardiologist Leading Studies and Guidelines on Implementation of GLP-1s

Innovations in Cardiovascular Medicine & Surgery | June 2024

6/6/2024 By UH and Ian Neeland, MD

Read Article

Balanced, Healthier Lives with the Science of CINEMA

Sadeer Al-Kindi, MD and Ian Neeland, MD discuss CINEMA, a center of excellecence that advances clinical excellence, promotes team science, and impacts the standard of care for patients with cardiometabolic disease.

2/16/2023 By Daniel Simon, MD, Ian Neeland, MD, and Sadeer Al-Kindi, MD

Read Article

Results are loading...